Scinovex
articleTop 1% cited

Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up

Leukemia · 2012 · Vol. 26(10) · pp. 2197–2203
Richard A. LarsonAndreas HochhausTimothy P. HughesRichard E. ClarkGabriel ÉtienneD. W. KimIan W. FlinnMineo KurokawaBeatriz MoiraghiR. YuRick E. BlakesleyNeil J. GallagherGiuseppe SaglioH. Kantarjian
Chronic Myeloid Leukemia TreatmentsEosinophilic Disorders and SyndromesChronic Lymphocytic Leukemia ResearchNilotinibImatinibMedicineMyeloid leukemiaDiscontinuationInternal medicineOncology

MeSH terms

Imatinib MesylateBenzamidesFollow-Up StudiesHumansPiperazinesPyrimidinesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveProtein Kinase Inhibitors

Funding

  • Novartis Pharmaceuticals Corporation
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.